Clinical trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to…
NCT03053193 · Agendia, Industry · Recruiting
Key facts
| NCT number | NCT03053193 |
|---|---|
| Title | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
| Official title | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX) |
| Acronym | FLEX |
| Lead sponsor | Agendia, Industry |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Breast Cancer |
| Intervention type | Diagnostic Test |
| Interventions | MammaPrint, BluePrint, and Full-Genome Testing |
| Enrollment | 30,000 |
| Start date | Apr 28, 2017 |
| Primary completion | Apr 1, 2037 |
| Completion | Dec 1, 2037 |
| First posted | Feb 15, 2017 |
| Last update posted | Aug 20, 2025 |
| Countries | Canada, Greece, Israel, United States |
At a glance
- 100–999 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: